Sara A. Hurvitz, MD, on Ribociclib Plus Endocrine Therapy for Premenopausal Women With Advanced Breast Cancer

Posted: Wednesday, July 3, 2019

Sara A. Hurvitz, MD, of the UCLA Jonsson Comprehensive Cancer Center, discusses the implications of the MONALEESA-7 trial for premenopausal women and how clinicians can address their patients’ concerns about altered hormonal status.